In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.

⁠Kristen Mittal LinkedIn⁠

⁠Mridul Mittal LinkedIn⁠

⁠Mittal Consulting LinkedIn⁠

⁠Mittal Consulting Website ⁠

⁠Duane Mancini LinkedIn⁠

⁠Project Medtech LinkedIn⁠

⁠Project Medtech Website